Le Lézard
Classified in: Health, Science and technology, Business
Subjects: PDT, SBS

Quotacy Partners with Samsung to Bring Life Insurance to the Launch of Bixby Marketplace


MINNEAPOLIS, Nov. 14, 2019 /PRNewswire/ -- Quotacy, an online life insurance broker, has joined Samsung's Bixby Marketplace as a premier developer partner. For the first time ever, people will be able to use voice commands to shop for life insurance on their Samsung devices. This partnership allows Quotacy to take a huge step towards attaining their goal of helping one million families protect their loved ones with life insurance. The Bixby integration adds to the growing list of Quotacy partnerships with some of the largest financial and review websites and third-party apps in the US.

"We're not looking to disrupt the life insurance industry. We will always be focused on helping people provide financial security for their loved ones," said Jeremy Hallett, CEO of Quotacy. "I've seen first-hand what a death without life insurance can do to a family, which is why we started Quotacy. With Bixby, it will allow us to help more families."

With Quotacy on Bixby, people can now use their voice and their Samsung device to shop for life insurance and even apply for coverage. Simply open your Samsung device and say, "Hi Bixby, ask Quotacy for life insurance quotes." Bixby will open up Quotacy and prompt you with a series of questions.

"Voice AI and natural language are the future of communication between consumers and services. To have the opportunity to partner with Samsung's Bixby Marketplace is really amazing. I'm proud to be part of a team that works hard to see emerging technology become a reality," said Chris Woolcott, Senior Information Architect at Quotacy.

About Quotacy
Quotacy is an independent online life insurance broker whose purpose is saving families one life insurance policy at a time. In minutes, customers can get free life insurance quotes and compare policies from top-rated life insurance companies all at once and easily apply online. After submitting an application, customers are paired with a personal Quotacy agent to take care of the legwork and to make sure they're getting the right coverage at the best possible price. Quotacy launched in 2014 and is headquartered in Minneapolis, MN.

For more information, visit the Quotacy website, blog, Facebook, LinkedIn and Twitter pages.

About Samsung Bixby
Bixby is an AI system that's designed to make device interaction easier, specifically to avoid the complexity of increasingly fully featured devices. It made its debut on Samsung's flagship mobile devices but is designed to work across a range of Samsung products from mobile, television, digital appliances and automobiles.

Media contact:
Abby Reddy
952.885.8626
[email protected]

SOURCE Quotacy


These press releases may also interest you

at 10:02
Boston Institute of Biotechnology, LLC (BIB) in collaboration with BIBo-Biopharma, proudly announces the successful completion of a groundbreaking 30,000L fermentation run, marking a significant milestone in biotechnology history....

at 10:00
Minister Responsible for Relations with the First Nations and the Inuit Ian Lafrenière today submitted in the National Assembly the third annual report on the administration of the Act to authorize the communication of personal information to the...

at 10:00
Cobb Outpatient Detox has opened a new facility in Marietta, GA, providing outpatient drug and alcohol detox services. The center aims to assist individuals in overcoming addiction while balancing their work and family commitments. Located near major...

at 10:00
A new report from the Health Care Cost Institute (HCCI) shows that, even with fluctuations in 2020 and 2021, per person health care spending grew from 2018 to 2022. Over the five years, average prices increased by 14% and utilization went up by about...

at 10:00
BioInnovation Institute (BII), an international non-profit foundation, incubating and accelerating world-class life science research, today announces the launch of the BII & Science Translational Medicine Prize for Innovations in Women´s Health and...

at 10:00
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with an entire industry chain, announced that the Phase I/II clinical study results of the novel Nectin-4-targeting ADC 9MW2821 for multiple advanced solid tumors will be presented...



News published on and distributed by: